A federal jury out of San Francisco came to a decision Tuesday, deciding that glyphosate was a substantial factor in the diagnosis of non-Hodgkin’s lymphoma in a man. Glyphosate is a component used in commercial herbicide product Roundup distributed by Monsanto.
What significance does this decision have?
The finding means that the trial is now allowed to proceed to its second phase (read more about the significance of the separate trial phases here) which is to determine whether Monsanto can be held liable for the diagnosis of non-Hodgkin’s lymphoma in the plaintiff, Edwin Hardeman’s.
Is this the first two-part trial of its kind?
Yes, at the federal level. There have been other trials at the state level (like Dewayne Johnson out of California – read about the result of his trial here). The state level cases tend to move faster according to an article posted by CNN.
How does this impact other Roundup lawsuits awaiting trial?
The impact remains to be seen at this time. A spokesperson for Bayer AG, who owns Monsanto, was quoted saying that the decision “has no impact on future cases and trials because each one has its own factual and legal circumstances.”
I have been diagnosed with non-Hodgkin’s lymphoma after using Roundup. What are my options?
If you or a loved one has been diagnosed with non-Hodgkin’s lymphoma after extended use of the Roundup product contact our office at (303) 327-9988 to schedule a free consultation and speak with one of our experienced attorneys. Please also visit our practice area page on Roundup here for additional information.